- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
First: Ganga Ram Hospital starts COVID Vaccine-Induced Thrombotic Thrombocytopenia testing facility
New Delhi: Delhi's premier Sir Ganga Ram Hospital has become the first centre in India to perform the confirmatory tests for Covid Vaccine-Induced Thrombotic Thrombocytopenia (VITT).
According to Dr. (Prof.) Jyoti Kotwal, Chairperson, Department of Hematology, Sir Ganga Ram Hospital, "Since the Index case of June 2021, we have received and diagnosed six more samples of VITT. Interestingly, five samples came from Kerala and one from neighbouring hospitals of Delhi." These samples came by courier to Sir Ganga Ram Hospital and due to timely diagnosis and advice for therapy, the lives of all other patients of VITT could be saved, she added.
Rare cases of blood clots and low platelets after receipt of adenovirus vector COVID-19 vaccines have been reported and are referred to as VITT or Thrombosis with Thrombocytopenia Syndrome (TTS).
Cases have been reported since early 2021 from Denmark, United Kingdom, Germany, and Canada and on 11th August 2021, the UN issued guidelines for diagnosis and management of TTS.
The gold standard confirmatory test is the presence of heparin dependant platelet aggregation of normal platelets by patient's serum in presence of a low dose of heparin. The Hematology Department at Sir Ganga Ram Hospital under Professor Jyoti Kotwal is the only center in India doing the gold standard Platelet aggregation test in the country. The samples of serum of suspected VITT are being received through courier and prompt diagnosis is made within 48 hours of receiving samples
The diagnosis is suspected if symptoms occur between day 3 to day 30 of vaccination and there is thrombocytopenia. Further, if d-dimer is raised and PF heparin antibody (HPF4 IgG) is present one can make a presumptive diagnosis
The incidence reported from the world is 1 in 100,000 to 1 in 127,000 vaccine doses. Sir Ganga Ram Hospital is the only center in the country doing the confirmatory test for diagnosis of VITT.
Awareness of the symptoms, diagnostic and confirmatory tests and the treatment of VITT is the need of the hour. Germany, UK and Canada issued diagnostic and treatment guidelines and later in August 2021, the WHO has issued guidelines for the same. The incidence reported Sir Ganga Ram hospital has been doing the diagnostic and confirmatory test since June 2021 and is a referral center that has since confirmed 7 cases of vaccine-induced thrombotic thrombocytopenia.
Also Read:Sir Ganga Ram Hospital reports first ever white fungus case in Delhi
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.